{{Rsnum
|rsid=10514345
|Gene=GPR98
|Chromosome=5
|position=91128462
|Orientation=plus
|GMAF=0.1915
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=GPR98
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 88.5 | 10.6 | 0.9
| HCB | 69.3 | 27.7 | 2.9
| JPT | 54.0 | 38.1 | 8.0
| YRI | 41.1 | 42.5 | 16.4
| ASW | 43.9 | 35.1 | 21.1
| CHB | 69.3 | 27.7 | 2.9
| CHD | 63.9 | 34.3 | 1.9
| GIH | 62.0 | 35.0 | 3.0
| LWK | 38.2 | 49.1 | 12.7
| MEX | 74.1 | 25.9 | 0.0
| MKK | 56.4 | 39.7 | 3.8
| TSI | 80.4 | 18.6 | 1.0
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs10514345
|PubMedID=17903296
|Condition=Hip geometry
|Gene=GPR98
|Risk Allele=
|pValue=2.00E-007
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs10514345
|Name_s=
|Gene_s=GPR98
|Feature=
|Evidence=PubMed ID:17903296; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association with bone mass and geometry in the Framingham Heart Study (Initial Sample Size: 1,141 individuals (Framingham); Replication Sample Size: NR). This variant is associated with Hip geometry.
|Drugs=
|Drug Classes=
|Diseases=Obesity
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356524
}}

{{PMID Auto
|PMID=19629617
|Title=Replication study of candidate genes/loci associated with osteoporosis based on genome-wide screening.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10514345
|overall_frequency_n=33
|overall_frequency_d=128
|overall_frequency=0.257812
|n_genomes=22
|n_genomes_annotated=0
|n_haplomes=27
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}